Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01144741 · ClinicalTrials.gov registry record

Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon Syndrome

A clinical trial, sponsored by Freeman-Sheldon Research Group.

Terminated
Registry status
2
Enrollment target

NCT01144741: Clinical Trial study, sponsored by Freeman-Sheldon Research Group.

NCT01144741 is a clinical trial that was terminated before completion, run by Freeman-Sheldon Research Group. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01144741 was terminated before completion, sponsored by Freeman-Sheldon Research Group.

TERMINATED
Registry status
2 participants
Enrollment target

Study Summary

Freeman-Sheldon syndrome (FSS) is a rare muscle disorder present before birth, involving primarily problems of the face and skull and the hands and feet. This is a study of problems, experiences, helpful treatments, and quality of life focusing on patients with FSS but including patients with Sheldon-Hall syndrome (SHS), distal arthrogryposis type 1 (DA1), and distal arthrogryposis type 3 (DA3), also called Gorden syndrome. These and related disorders are very challenging to treat, partly because the big differences in individual patients and lack of information on previous clinical experience with treatment options. It is hoped the study will identify areas for further research in physiology and therapy. This study will cover all types of treatment \[medical (non-surgical), including psychiatric, and surgical treatments\], even unconventional. It also includes questions about effects on the patient's thoughts, feelings, quality of life, and relationship with siblings, family, and parents' and if any intervention was required or advised. This study will also look for similarities and differences in patients who meet the head and face part of the diagnostic criteria but do not meet all other parts and patients who met the full diagnostic criteria. There will be questions about problems or experiences to investigate if both groups of patients may have the same syndrome. Treatment success depends on getting a correct diagnosis.

Primary Outcome

The frequency to which certain features of the syndromes contribute to mortality or morbidity, especially life-long functional impairment.

Interventions

  • OTHER Modified Flanagan Quality of Life Scale
  • OTHER PTSD Checklist-Civilian (PCL-C)
  • OTHER Center for Epidemiologic Studies Depression Scale (CES-D)
  • OTHER Functional Enquiry (or Review of Systems) Form
  • OTHER Study of Therapeutic Outcomes and Practices in Freeman-Sheldon Syndrome (STOP-FSS) Questionnaire

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2010-02
Est. Completion 2022-06-14
Freeman-Sheldon Research Group

3 total trials

Why NCT01144741 stopped before completion

NCT01144741 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.

The record links to 0 conditions, and to 5 interventions - of which Modified Flanagan Quality of Life Scale is the first listed.

NCT01144741 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01144741 about?

NCT01144741 is a clinical study titled "Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon Syndrome". Freeman-Sheldon syndrome (FSS) is a rare muscle disorder present before birth, involving primarily problems of the face and skull and the hands and feet. This is a study of problems, experiences, helpful treatments, and quality of life focusing on patients with FSS but including patients with Sheld...

What is the current status of trial NCT01144741?

This trial is currently terminated. The enrollment target is 2 participants. The study started on 2010-02. Estimated completion is 2022-06-14.

What interventions are being tested in trial NCT01144741?

The interventions under investigation include: Modified Flanagan Quality of Life Scale (OTHER), PTSD Checklist-Civilian (PCL-C) (OTHER), Center for Epidemiologic Studies Depression Scale (CES-D) (OTHER), Functional Enquiry (or Review of Systems) Form (OTHER), Study of Therapeutic Outcomes and Practices in Freeman-Sheldon Syndrome (STOP-FSS) Questionnaire (OTHER).

Who is sponsoring clinical trial NCT01144741?

This trial is sponsored by Freeman-Sheldon Research Group, which has 3 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01144741, the US trial registry maintained by the National Library of Medicine. NCT01144741 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.